Amalgamated Bank’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.9M | Sell |
33,698
-2,632
| -7% | -$231K | 0.02% | 671 |
|
|
2026
Q1 | $3.29M | Sell |
36,330
-1,058
| -3% | -$97.1K | 0.03% | 592 |
|
|
2025
Q4 | $3.36M | Sell |
37,388
-371
| -1% | -$35.2K | 0.02% | 582 |
|
|
2025
Q3 | $3.72M | Sell |
37,759
-703
| -2% | -$69.7K | 0.03% | 546 |
|
|
2025
Q2 | $3.51M | Sell |
38,462
-205
| -0.5% | -$19.8K | 0.03% | 547 |
|
|
2025
Q1 | $4.38M | Buy |
38,667
+348
| +0.9% | +$37.2K | 0.04% | 418 |
|
|
2024
Q4 | $4.05M | Sell |
38,319
-1,763
| -4% | -$189K | 0.03% | 481 |
|
|
2024
Q3 | $4.33M | Sell |
40,082
-1,733
| -4% | -$189K | 0.04% | 445 |
|
|
2024
Q2 | $4.54M | Sell |
41,815
-1,670
| -4% | -$197K | 0.04% | 464 |
|
|
2024
Q1 | $5.74M | Sell |
43,485
-6,801
| -14% | -$850K | 0.05% | 383 |
|
|
2023
Q4 | $6.12M | Sell |
50,286
-5,880
| -10% | -$656K | 0.05% | 376 |
|
|
2023
Q3 | $6.3M | Buy |
56,166
+1,631
| +3% | +$207K | 0.05% | 329 |
|
|
2023
Q2 | $7.94M | Buy |
54,535
+452
| +0.8% | +$61.4K | 0.06% | 263 |
|
|
2023
Q1 | $6.99M | Sell |
54,083
-588
| -1% | -$73.8K | 0.06% | 301 |
|
|
2022
Q4 | $6.97M | Buy |
54,671
+1,537
| +3% | +$178K | 0.06% | 303 |
|
|
2022
Q3 | $5.55M | Sell |
53,134
-46
| -0.1% | -$5.05K | 0.05% | 335 |
|
|
2022
Q2 | $5.59M | Buy |
53,180
+676
| +1% | +$80.2K | 0.05% | 354 |
|
|
2022
Q1 | $6.71M | Sell |
52,504
-5,429
| -9% | -$654K | 0.05% | 334 |
|
|
2021
Q4 | $7.14M | Sell |
57,933
-824
| -1% | -$108K | 0.05% | 337 |
|
|
2021
Q3 | $8.35M | Sell |
58,757
-1,966
| -3% | -$289K | 0.07% | 255 |
|
|
2021
Q2 | $9.48M | Buy |
60,723
+49,064
| +421% | +$7.95M | 0.08% | 236 |
|
|
2021
Q1 | $1.81M | Sell |
11,659
-429
| -4% | -$66.5K | 0.07% | 271 |
|
|
2020
Q4 | $1.81M | Sell |
12,088
-18
| -0.1% | -$2.54K | 0.07% | 269 |
|
|
2020
Q3 | $1.6M | Sell |
12,106
-255
| -2% | -$33.3K | 0.07% | 266 |
|
|
2020
Q2 | $1.43M | Sell |
12,361
-18,501
| -60% | -$2.13M | 0.07% | 272 |
|
|
2020
Q1 | $3.03M | Sell |
30,862
-1,147
| -4% | -$150K | 0.07% | 235 |
|
|
2019
Q4 | $4.65M | Buy |
32,009
+2,349
| +8% | +$324K | 0.09% | 202 |
|
|
2019
Q3 | $3.95M | Sell |
29,660
-597
| -2% | -$77.1K | 0.08% | 221 |
|
|
2019
Q2 | $3.46M | Buy |
30,257
+3,669
| +14% | +$430K | 0.08% | 225 |
|
|
2019
Q1 | $3.3M | Buy |
26,588
+730
| +3% | +$83K | 0.08% | 224 |
|
|
2018
Q4 | $2.6M | Sell |
25,858
-489
| -2% | -$55K | 0.07% | 238 |
|
|
2018
Q3 | $3.36M | Sell |
26,347
-630
| -2% | -$74.9K | 0.08% | 219 |
|
|
2018
Q2 | $2.92M | Buy |
26,977
+1,091
| +4% | +$119K | 0.07% | 243 |
|
|
2018
Q1 | $2.74M | Sell |
25,886
-315
| -1% | -$36.6K | 0.07% | 261 |
|
|
2017
Q4 | $3.07M | Buy |
26,201
+2,333
| +10% | +$264K | 0.08% | 227 |
|
|
2017
Q3 | $2.71M | Buy |
23,868
+730
| +3% | +$84.3K | 0.08% | 224 |
|
|
2017
Q2 | $2.88M | Buy |
23,138
+8,978
| +63% | +$1.06M | 0.09% | 204 |
|
|
2017
Q1 | $1.68M | Sell |
14,160
-2,940
| -17% | -$333K | 0.08% | 222 |
|
|
2016
Q4 | $1.71M | Buy |
17,100
+3,605
| +27% | +$386K | 0.08% | 234 |
|
|
2016
Q3 | $1.7M | Buy |
13,495
+50
| +0.4% | +$6.18K | 0.1% | 191 |
|
|
2016
Q2 | $1.69M | Buy |
13,445
+7,087
| +111% | +$802K | 0.1% | 191 |
|
|
2016
Q1 | $658K | Buy |
6,358
+1,700
| +36% | +$164K | 0.06% | 383 |
|
|
2015
Q4 | $464K | Sell |
4,658
-1,485
| -24% | -$145K | 0.06% | 488 |
|
|
2015
Q3 | $560K | Buy |
6,143
+177
| +3% | +$17.7K | 0.06% | 443 |
|
|
2015
Q2 | $633K | Buy |
5,966
+407
| +7% | +$45K | 0.06% | 410 |
|
|
2015
Q1 | $634K | Buy |
5,559
+1,409
| +34% | +$161K | 0.08% | 325 |
|
|
2014
Q4 | $457K | Sell |
4,150
-679
| -14% | -$71.6K | 0.07% | 374 |
|
|
2014
Q3 | $471K | Buy |
4,829
+61
| +1% | +$6K | 0.07% | 368 |
|
|
2014
Q2 | $481K | Buy |
4,768
+535
| +13% | +$52.2K | 0.07% | 354 |
|
|
2014
Q1 | $389K | Sell |
4,233
-82
| -2% | -$7.56K | 0.07% | 422 |
|
|
2013
Q4 | $390K | Buy |
+4,315
| New | +$373K | 0.07% | 428 |
|
Other funds holding ZBH
EIC
SCM
BTW
Amalgamated Bank's ZBH Position: Q2 2026 in Review
Amalgamated Bank reduced its Zimmer Biomet (ZBH) stake by 7.2% in Q2 2026, selling an estimated $231K and leaving 33,698 shares worth $2.9M. The position accounts for 0.02% of the portfolio, ranked #671.
Amalgamated Bank first reported a position in ZBH in Q4 2013 and has held it in 51 quarters since. The position peaked at $9.48M in Q2 2021. 498 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Amalgamated Bank held 33,698 shares of Zimmer Biomet worth $2.9M as of Q2 2026.
- Amalgamated Bank sold 2,632 Zimmer Biomet shares in Q2 2026, an estimated $231K.
- Zimmer Biomet made up 0.02% of Amalgamated Bank's portfolio in Q2 2026, its #671 holding.
- Amalgamated Bank first reported a position in Zimmer Biomet in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Zimmer Biomet position peaked at $9.48M in Q2 2021.
- 498 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.